References
Larsen P.R. Thyroid-pituitary interaction. Feedback regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med. 306: 23, 1982.
Burger H.G., Patel Y.C. TSH and TRH: their physiological regulation and clinical application of TRH. In: Martini L., Besser G.M. (Eds.). Clinical Neuroendocrinology. Academic Press, New York, 1977, p. 67.
Scanion M.F., Pourmand M., McGregor A.M., Rodriguez-Arnao M.D., Hall K., Gomez-Pan A., Hall R. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. J. Endocrinol. Invest. 2: 307, 1979.
Morley J.E. Neuroendocrine control of thyrotropin secretion. Endocr. Rev. 2: 396, 1981.
Peters J.R., Foord S.M., Dieguez C., Scanion M.F. TSH neuroregulation and alterations in disease states. Clin. Endocrinol. Metab. 12: 669, 1983.
Kaplan S.L., Grumbach M.M., Aubert M.L. The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system; regulation of anterior pituitary function. Recent Prog. Horm. Res. 32: 161, 1976.
Gluckman P.D., Grumbach M.M., Kaplan S.L. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr. Rev. 2: 363, 1981.
Fisher D.A., Klein A.H. Thyroid development and disorders of thyroid function in the newborn. N. Engl. J. Med. 304: 702, 1981.
Thliveris J.A., Currie R.W. Observations on the hypothalamus-hypophyseal portal vasculature in the developing human fetus. Am. J. Anat. 157: 441, 1980.
Fisher D.A., Dussault J.H., Sack J., Chopra I.J. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog. Horm. Res. 33: 59, 1977.
Falin F.I. The development of human hypophysis and differentiation of cells of its anterior lobe during embryonic life. Acta Anat. 44: 188, 1961.
Conklin J.L The development of the human fetal adenohypophysis. Anat. Rec. 160: 79, 1968.
Baker B.L., Jaffe R.B. The genesis of cell types in the adenohypophysis of the human fetus as observed with immunocytochemistry. Am. J. Anat. 143: 137, 1975.
Dubois P.M., Begeot M. Immunocytological localization of LH, FSH, TSH and their subunits in the pituitary of normal and anencephalic human fetuses. Cell Tissue Res. 191: 249, 1978.
Hatakeyama S. Electron microscopic study of the anencephalic adenohypophysis with reference to the adrenocorticotrophs and their correlation with the functional differentiation of the hypothalamus during the foetal life. Endocrinol. (Jpn.) 16: 187, 1969.
Fukuchi M., Inove J., Abe H., Kumahara Y. Thyrotropin in human fetal pituitaries. J. Clin. Endocrinol. Metab. 31: 565, 1970.
Bugnon C., Block B., Fellman D. Etudes cyto-immunologiques des cellules gonadotropes des foetus humain. Bull. Assoc. Anat. 60: 259, 1976.
Fisher D.A., Hobel C.J., Garza R., Pierce C.A. Thyroid function in the preterm fetus. Pediatrics 40: 208, 1970.
Roti E., Benassi L., Bandini P., Robuschi G., Alfieri L., Gnudi A. Thyroid hormone levels in cord serum from at term, premature and small for gestational age newborns. In: Salvadori B., Bacchi-Modena A. (Eds.)., Poor intrauterine fetal growth. Edizioni Minerva Medica, Parma, 1977, p. 593.
Fisher D.A., Odell W.D., Hobel C.J., Garza R. Thyroid function in the term fetus. Pediatrics 44: 526, 1969.
Roti E., Robuschi G., Emanuele R., Benassi L., Bandini P., Russo A., Gnudi A. Concentrazioni di tiroxina, triiodotironina, reverse T3, tireotropo e tireoglobulina nel sangue del cordone ed in quello materno. Minerva Pediatr. 33: 843, 1981.
Chopra I.J., Crandall B.F. Thyroid hormones and thyrotropin in amniotic fluid. N. Engl. J. Med. 293: 740, 1975.
Roti E., Malavasi F., Bandini P., Robuschi G., Benassi L., Gnudi A. 3, 3′, 5′-triiodothyronine concentrations in amniotic fluid at different ages of pregnancy. J. Endocrinol. Invest. 2: 213, 1979.
Kourides I.A., Heath C., Ginsberg-Fellner F. Measurement of thyroid stimulating hormone in human amniotic fluid. J. Clin. Endocrinol. Metab. 54: 635, 1982.
Hollingsworth D.R., Alexander N.M. Amniotic fluid concentrations of iodothyronines and thyrotropin do not reliably predict fetal thyroid status in pregnancies complicated by maternal thyroid disorders or anencephaly. J. Clin. Endocrinol. Metab. 57: 349, 1983.
Yoshida K., Sakurada T., Takahashi T., Furuhashi N., Kaise K., Yoshinaga K. Measurement of TSH in human amnioticfluid: diagnosis of fetal thyroid abnormality in utero. Clin. Endocrinol. (Oxf.) 25: 313, 1986.
Robuschi G., Braverman L.E., Emanuele R., d’Amato L., Gardini E., Foscolo M.S., Gualerzi C., Benassi L., Gnudi A., Roti E. Amniotic fluid thyrotropin (TSH) does not reflect elevated fetal serum TSH following maternal administration of thyrotropin releasing hormone. J. Perinat. Med. 13: 219, 1985.
Kourides I.A., Berkowitz R.L., Pang S., Van Natta F.C., Barone C.M., Ginsberg-Fellner F. Antepartum diagnosis of goitrous hypothyroidism by fetal ultrasonography and amniotic fluid thyrotropin concentration. J. Clin. Endocrinol. Metab. 59: 1016, 1984.
Fisher D.A. The unique endocrine milieu of the fetus. J. Clin. Invest. 78: 603, 1986.
Christianson D., Roti E., Vagenakis A., Braverman L.E. The sex-related difference in serum thyrotropin concentration is androgen mediated. Endocrinology 108: 529, 1981.
Kieffer J.D., Mover H., Federico P., Maalof F. Pituitary-thyroid axis in neonatal and adult rats: comparison of the sexes. Endocrinology 98: 295, 1976.
Roti E., Gnudi A., Robuschi G., Bandini P., Alfieri A., Benassi L. Ormoni tiroidei nel sangue del funicolo ombelicale: rapporti coi livelli materni, età gestazionale e peso corporeo del neonato. In: Giornate Endocrinologiche Pisane. Pacini Editore, Pisa, 1977, p. 991.
Pacini F., Lari R., La Ricca P., Grasso L., Taddei D., Bardini N., Fenzi G.F., Di Bartolo F., Baschieri L., Pinchera A. Serum thyroglobulin in newborns’cord blood in childood and adolescence: a physiological indicator of thyroid status. J. Endocrinol. Invest. 7: 467, 1984.
Hirano T., Singh J., Srinivasan G., Pildes R. Post-natal thyroid function in low birth weight infants; a longitudinal assessment of free thyroxine and thyroid hormone binding globulin. Acta Endocrinol. (Kbh.) 110: 56, 1985.
Penny R., Spencer C.A., Frasier S.D., Nicoloff J.T. Cord serum thyroid stimulating hormone and thyroglobulin levels decline with increasing birth weight in newborns. J. Clin. Endocrinol. Metab. 59: 979, 1984.
Villena A., Pretell E.A., Manucci E., Wong E. Perinatal pituitary thyroid function at high altitude. In: Medeiros-Neto G., Gaitan E. (Eds.), Frontiers in thyroidology. Plenum Medical Book Company, New York, 1986, vol. 1, p. 243.
Rogowski P., Siesbaek-Nielsen K., Hansen J.M. Seasonal variation in neonatal thyroid function. J. Clin. Endocrinol. Metab. 39: 919, 1974.
Fisher D.A., Odell W.D. Acute release of thyrotropin in the newborn. J. Clin. Invest. 48: 1670, 1969.
Czemichow P., Greenberg A.H., Tyson J., Blizzard R. Thyroid function studied in paired maternal cord sera and subsequential observations of thyrotropic hormone release during the first 72 hours of life. Pediatr. Res. 5: 53, 1971.
Jacobsen B.B., Andersen H.J., Peitersen B., Dige-Petersen H., Hummer L. Serum levels of thyrotropin, thyroxine and triiodothyronine in full-term, small-for-gestational age and preterm newborn babies. Acta Paediatr. Scand. 66: 681, 1977.
Klein A.H., Foley B., Kenny F.M., Fisher D.A. Thyroid hormone and thyrotropin responses to parturition in premature infants with and without the respiratory distress syndrome. Pediatrics 63: 380, 1970.
Sack J., Fisher D.A., Wang C.C. Serum thyrotropin, prolactin and growth hormone levels during the early neonatal period in human infant. J. Pediatr. 89: 298, 1976.
Oddie T.H., Bernard B., Presley M., Klein A.H., Fisher D.A. Damped oscillations in serum thyroid hormone levels of normal newborn infants. J. Clin. Endocrinol. Metab. 47: 61, 1978.
Breall J.A., Rudolph A.M., Heymann M.A. Role of thyroid hormone in postnatal circulatory and metabolic adjustments. J. Clin. Invest. 73: 1418, 1984.
Wu S.Y., Polk D.H., Klein A.H., Fisher D.A. The mechanism of low serum T3 in the fetus: hepatic T4-5′-monodeiodinase versus tissue sulfhydryl content — a clarification. J. Develop. Physiol. 8: 43, 1986.
Shepard T.H. Onset of function in the human fetal thyroid: biochemical and radioautographic studies from organ culture. J. Clin. Endocrinol. Metab. 27: 945, 1967.
Costa A., De Filippis B., Panizzo M., Girardi G., Bertino E., Arisio R., Mostert M., Trapani G., Fabris C. Development of thyroid function between VI–IX month of fetal life in humans. J. Endocrinol. Invest. 9: 273, 1986.
Greenberg A., Czernichow P., Reba R.C., Tyson J., Blizzard R.M. Observation on the maturation of thyroid function in early fetal life. J. Clin. Invest. 49: 1790, 1970.
Oddie T.H., Fisher D.A., Bernard B., Lam R.W. Thyroid function at birth in infants of 30 to 45 weeks’ gestation. J. Pediatr. 90: 803, 1977.
Wilson D.M., Hopper A.O., McDougall I.R., Monika F.B., Hintz R.L., Stevenson D.K., Rosenfeld R.G. Serum free thyroxine values in term, premature and sick infants. J. Pediatr. 101: 113, 1982.
Ekins R. Roles of serum thyroxine-binding proteins and maternal thyroid hormones in fetal development. Lancet 1: 1129, 1985.
Obregon M.J., Mallol J., Pastor R., Morreale De Escobar G., Escobar Del Rey F. L-thyroxine and 3, 5, 3′-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology 114: 305, 1984.
Wrutniak C., Cabello G., Bosch M. Plasma free and total iodothyronine levels in hypophysectomized and intact lamb foetuses during the last third of gestation. Acta Endocrinol. (Kbh.) 110: 388, 1985.
Roti E., Fang S.L., Green K., Emerson C.H., Braverman L.E. Human placenta is an active site of thyroxine and 3, 3′, 5-triiodothyronine thyrosyl ring deiodination. J. Clin. Endocrinol. Metab. 53: 498, 1981.
Roti E., Fang S.L., Braverman L.E., Emerson C.H. Rat placenta is an active site of inner ring deiodination of thyroxine and 3, 3′, 5-triiodothyronine. Endocrinology 810: 34, 1982.
Roti E., Braverman L.E., Fang S.L., Alex S., Emerson C.H. Ontogenesis of placental inner ring thyroxine deiodinase and amniotic fluid 3, 3′, 5′-triiodothyronine concentration in the rat. Endocrinology 111: 959, 1982.
Morreale De Escobar G., Pastor R., Obregon M.J., Escobar Del Rey F. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 117: 1890, 1985.
Cheron R.G., Kaplan M.M., Selenkow H.A., Crigler J.F. Jr. Neonatal thyroid function after propylthiouracil therapy fpr maternal Graves’ disease. N. Engl. J. Med. 304: 525, 1981.
Momotani N., Noh J., Oyanagy H., Ishikawa N., Ito K. Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status. N. Engl. J. Med. 315: 24, 1986.
Robuschi G., Montermini M., Alboni A., Borciani E., Cersosimo G., Negrotti L., Gnudi A., Safran M., Braverman L.E., Roti E. Cord blood iodothyronine and thyrotropin concentrations in newborns of mothers exposed to povidone iodine in the last trimester of pregnancy. J. Endocrinol. Invest. 10: 183, 1987.
Lightner E.S., Fisher D.A., Giles H., Woolfenden J. Intra-amniotic injection of thyroxine (T4) to a human fetus. Evidence for conversion of T4 to reverse T3. Am. J. Obstet. Gynecol. 127: 487, 1977.
Melmed S., Harada A., Murata Y., Socol M., Reed A., Carlson H.E:, Azukizawa M., Martini C., Jorgensen E., Hershman J.M. Fetal response to thyrotropin-releasing hormone after thyroid hormone administration to the Rhesus Monkey: lack of pituitary suppression. Endocrinology 105: 334, 1979.
Klein A.H., Fisher D.A. Thyrotropin-releasing hormone stimulated pituitary and thyroid gland responsiveness and 3, 5, 3’-triiodothyro-nine suppression in fetal and neonatal lambs. Endocrinology 106: 697, 1980.
Fukiishi Y., Itasegawa Y. Ontogeny of thyrotropin concentration in perinatal rats. Acta Endocrinol. (Kbh.) 110: 95, 1985.
Walker P., Coulombe P., Dussault J.H. Effects of triiodothyronine on thyrotropin-releasing hormone-induced thyrotropin release in the neonatal rat. Endocrinology 107: 1731, 1980.
Perry R.A., McIntosh G.H., Robinson P.M. Ultrastructural detection of the onset of pituitary thyrotroph sensitivity to lowered thyroid hormone concentrations in the fetal sheep. Acta Anat. 117: 42, 1983.
Tamagna E.I., Hershman J.M., Jorgensen E.C. Thyrotropin suppression by 3, 5-dimethyl-3’ isopropyl-L-thyronine in man. J. Clin. Endocrinol. Metab. 48: 196, 1979.
Comite F., Burrow G.N., Jorgensen E.C. Thyroid hormone analogs and fetal goiter. Endocrinology 102: 1670, 1978.
Bachrach L.K., Dibattista D., Burrow G.N., Holland F.J. Transplacental effects of 3, 5-dimethyl-3′-isopropyl-L-thyronine on fetal hypothyroidism in primates. Endocrinology 112: 2021, 1983.
Bachrach L.K., Kudlow J.E., Silverberg J.D.H., Kent G., Borrow G.N. Treatment of ovine cretinism in utero with 3,5-dymethyl-3′ isopropyl-L-thyronine. Endocrinology 111: 132, 1982.
Visser T.J., Leonard J.L., Kaplan M.M., Larsen P.R. Different pathways of iodothyronine 5′-deiodination in rat cerebral cortex. Biochem. Biophys. Res. Commun. 101: 1297, 1981.
Visser T.J., Leonard J.L., Kaplan M.M., Larsen P.R. Kinetic evidence suggesting two mechanisms for iodothyronine 5′-deiodination in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 79: 5080, 1982.
Cheron R.G., Kaplan M.M., Larsen P.R. Divergent changes of thyroxine 5-monodeiodination in rat pituitary and liver during maturation. Endocrinology 106: 1405, 1980.
El-Zaheri M.M., Braverman L.E., Vagenakis A.G. Enhanced conversion of thyroxine to triiodothyronine by the neonatal rat pituitary. Endocrinology 106: 1735, 1980.
McCann U.D., Shaw E.A., Kaplan M.M. Iodothyronine deiodination reaction types in several rat tissues: effects of age, thyroid status, and glucocorticoid treatment. Endocrinology 114: 1513, 1984.
Segall-Blank M., Connolly J.L., Ingbar S.H. Comparative studies of the metabolism of thyroxine in the pituitaries of pregnant sheep and their fetuses. Endocrinology 111: 996, 1982.
Naito K., Inada M., Mashio Y., Tanaka K., Ishii H., Nishikawa M., Imura H. Reciprocal relation between serum thyrotropin levels and intrapituitary 3, 5, 3′-L-triiodothyronine generating activity from thyroxine in perinatal rats. Endocrinol. Jpn. 28: 461, 1981.
Bernal J., Pekonen F. Ontogenesis of the nuclear 3, 5, 3′-triiotlothyronine receptor in the human fetal brain. Endocrinology 114: 677, 1984.
Perez Castillo A., Bernal J., Ferreiro B., Pans T. The early ontogenesis of thyroid hormone receptor in the rat fetus. Endocrinology 117: 2457, 1985.
Schwartz H.L., Oppenheimer J.H. Ontogenesis of 3, 5, 3′-triiodothyronine receptors in neonatal rat brain: dissociation between receptor concentrations and stimulation of oxygen consumption by 3, 5, 3′-triiodothyronine. Endocrinology 103: 943, 1978.
Coulombe P., Ruel J., Faure R., Dussault J.H. Pituitary nuclear triiodothyronine receptors during development in the rat. Am. J. Physiol. 245: E81, 1983.
Azizi F., Vagenakis A.G., Bollinger J., Reichlin S., Braverman L.E., Ingbar S.H. Persistent abnormalities in pituitary function following neonatal thyrotoxicosis in the rat. Endocrinology 94: 1681, 1974.
Dussault J.A., Coulombe P., Walker P. Effects of neonatal hyperthyroidism on the development of the hypothalamic pituitary-thyroid axis in the rat. Endocrinology 110: 1037, 1982.
Besa M.E., Pascual-Leone A.M. Effect of neonatal hyperthyroidism upon the regulation of TSH secretion in rats. Acta Endocrinol. (Kbh.) 105: 31, 1984.
Walker P., Courtin F. Transient neonatal hyperthyroidism results in hyperthyroidism in the adult rat. Endocrinology 116: 2246, 1985.
Porterfield S.P. Prenatal exposure of the fetal rat to excessive L-thyroxine or 3, 5-Dimethyl-3′isopropyl-thyronine produces persistent changes in the thyroid control system. Horm. Metab. Res. 17: 655, 1985.
Bakke J.L., Lawrence N.L., Bennett J., Robinson S. Endocrine syndromes produced by neonatal hyperthyroidism, hypothyroidism, or altered nutrition and effects seen in untreated progeny. In: Fisher D.A., Burrow G.N. (Eds.), Perinatal thyroid physiology and disease. Raven Press, New York, 1975, p. 79.
Homoki J., Birk J., Lods U., Rothenbuchner G., Fazekas A.T.A., Teller W.M. Thyroid function in newborns with congenital goiter. J. Pediatr. 86: 753, 1975.
Sato T., Suzuki Y., Taketani T., Ishiguro K., Nakajuma H. Age related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism. J. Clin. Endocrinol. Metab. 44: 553, 1977.
Schultz R., Glassman M., Macgillivaray H. Elevated threshold for thyrotroph suppression in congenital hypothyroidism. Am. J. Dis. Child. 134: 19, 1980.
Redmond G.P., Soyka L.F. Abnormal TSH secretory dynamic in congenital hypothyroidism. J. Pediatr. 98: 83, 1981.
Focarile F., Rondanini G.F., Bollati A., Bartolucci A., Chiumello G. Free thyroid hormones in evaluating persistently elevated thyrotropin levels in children with congenital hypothyroidism on replacement therapy. J. Clin. Endocrinol. Metab. 59: 1211, 1984.
Silva E.J., Matthews P.S. Production rates and turnover of triiodothyronine in rat developing cerebral cortex and cerebellum responses to hypothyroidism. J. Clin. Invest. 74: 1035, 1984.
Cavaliere H., Medeiros Neto G.A., Rosner W., Kourides I.A. Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism. J. Endocrinol. Invest. 8: 527, 1985.
Jackson I.M.D. Thyrotropin-releasing hormone. N. Engl. J. Med. 306: 145, 1982.
Winters A.J., Eskay R.L., Porter J.C. Concentration and distribution of TRH and LRH in the human fetal brain. J. Clin. Endocrinol. Metab. 39: 960, 1974.
Aubert M.L., Grumbach M.M., Kaplan S.L. The ontogenesis of human fetal hormones. IV. Somatostatin, luteinizing hormone releasing factor, and thyrotropin releasing factor in hypothalamus and cerebral cortex of human fetuses 10–22 weeks of age. J. Clin. Endocrinol. Metab. 44: 1130, 1977.
Lamberton R.P., Lechan R.M., Jackson I.M.D. Ontogeny of thyrotropin-releasing hormone and histidyl-prolinediketopiperazine in the rat central nervous system and pancreas. Endocrinology 115: 2400, 1984.
Gayo L., Bonet B., Herranz A.S., Iglesias R., Toro M.J., Montoya E. Postnatal development of brain TRH, serum TSH and thyroid hormones in the male and female rat. Acta Endocrinol. (Kbh.) 112: 7, 1986.
Lombardi G., Lupoli G., Scopacasa F., Panza R., Minozzi M. Plasma immunoreactive thyrotropin-releasing hormone (TRH) values in normal newborns. J. Endocrinol. Invest. 1: 69, 1978.
Gibbons J.M., Mitnick M., Chieffo V. In vitro biosynthesis of TSH-and LH-releasing factors by the human placenta. Am. J. Obstet. Gynecol. 121: 127, 1975.
Shambaugh G. III, Kubek M., Wilber J.F. Thyrotropin-releasing hormone activity in the human placenta. J. Clin. Endocrinol. Metab. 48: 483, 1979.
Youngblood W.W., Humm J., Dizer J.S. TRH-like immunoreactivity in rat pancreas and eye bovine and sheep pineals, and human placenta: non-identity with synthetic pyroglu-his-pro-NH2 (TRH). Brain Res. 163: 101, 1979.
Morley J.E., Bashore R.A., Reed A., Carlson H.E., Hershman J.M. Thyrotropin-releasing hormone and thyroid hormones in amniotic fluid. Am. J. Obstet. Gynecol. 134: 581, 1979.
Engler D., Scanion M.F., Jackson I. Thyrotropin-releasing hormone in the systemic circulation of the neonatal rat is derived from the pancreas and other extraneural tissues. J. Clin. Invest. 67: 800, 1981.
Banerji A., Prasad C. The postnatal development of the pituitary thyrotropinreleasing hormone receptor in male and female rats. Endocrinology 110: 663, 1982.
Dussault J.H., Coulombe P. Pituitary receptors during development in the rat. I. TRH binding capacity. Pediatr. Res. 17: 270, 1983.
Pezzino V., Distefano G., Belfiore A., Filetti S., Mazzone D., Grasso S. Role of thyrotropin-releasing hormone in the development of pituitary-thyroid axis in four anencephalic infants. Acta Endocrinol. (Kbh.) 101: 538, 1982.
Grasso S., Filetti S., Mazzone D., Pezzino V., Vigo R., Vigneri R. Thyroid-pituitary function in eight anencephalic infants. Acta Endocrinol. (Kbh.) 93: 396, 1980.
Theodoropoulos T., Braverman L.E., Vagenakis A.G. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat. J. Clin. Invest. 63: 588, 1979.
Oliver C., Giraud P., Lissitzky J.C., Conte-Delvox B., Gillioz P. Influence of thyrotropin-releasing hormone on the secretion of thyrotropin in neonatal rats. Endocrinology 108: 179, 1981.
Strbak V., Greer M.A. Acute effects of hypothalamic ablation on plasma thyrotropin and prolactin concentrations in the suckling rat: evidence that early postnatal pituitary-thyroid regulation is independent of hypothalamic control. Endocrinology 105: 488, 1979.
Tonooka N., Greer M.A. Evidence that control of fetal thyrotropic secretion is independent of both the fetal and maternal hypothalamus. Endocrinology 102: 852, 1978.
Allen J.P., Greer M.A., McGilvra R., Castro A., Fisher D.A. Endocrine function in an anencephalic infant. J. Clin. Endocrinol. Metab. 38: 94, 1974.
De Luca F., Trimarchi F., Carducci Artenisio A., Abate F., Baviera G., Cucinotta D., Gemelli M. Studio funzionale dell’adenoipofisi in due neonati anencefalici. J. Endocrinol. Invest. 4 (Suppl. 1): 19, 1981.
Azukizawa M., Murata Y., Ikenoue T., Martin C.B., Hershman J.M. Effect of thyrotropin-releasing hormone on secretion of thyrotropin, prolactin, thyroxine, and triiodothyronine in pregnant and fetal Rhesus Monkey. J. Clin. Endocrinol. Metab. 43: 1020, 1976.
Roti E., Gnudi A., Braverman L.E., Robuschi G., Emanuele R., Bandini P., Benassi L., Pagliani A., Emerson C.H. Human cord blood concentration of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 53: 813, 1981.
Jacobsen B.B., Andersen H., Dige-Petersen H., Hummer L. Thyrotropin response to thyrotropin-releasing hormone in full term, euthyroid and hypothyroid newborns. Acta Pediatr. Scand. 65: 433, 1976.
Jacobsen B.B., Andersen H., Dige-Petersen H., Hummer L. Pituitary-thyroid responsiveness to thyrotropin-releasing hormone in preterm and small-for gestational age newborns. Acta Pediatr. Scand. 66: 541, 1977.
Neary J.T., Nakamura C., Davies I.J., Soodak M., Maloof F. Lower levels of thyrotropin-releasing hormone degrading activity in human cord and in maternal sera than in the serum of euthyroid, non pregnant adults. J. Clin. Invest. 62: 1, 1978.
Aratan-Spire S., Czernichow P. Thyrotropin-releasing hormone degrading activity of neonatal human plasma. J. Clin. Endocrinol. Metab. 50: 88, 1980.
Snyder P.J., Utiger R.D. Response to thyrotropin-releasing hormone (TRH) in normal man. J. Clin. Endocrinol. Metab. 34: 380, 1972.
Roti E., Gnudi A., Robuschi G., Emanuele R., Benassi L., Braverman L.E. Response of growth hormone to thyrotropin-releasing hormone (TRH) during fetal life. J. Clin. Endocrinol. Metab. 54: 1255, 1982.
Reichlin S. Somatostatin. N. Engl. J. Med. 309: 1495, 1983.
Bugnon C., Fellman D., Bloch B. Immunocytochemical study of the ontogenesis of the hypothalamic somatostatin-containing neurons in the human fetus. Cell Tissue Res. 183: 319, 1977.
Saito H., Saito S., Sano T., Hosoi E., Saito H. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation. J. Clin. Endocrinol. Metab. 56: 567, 1983.
Koshimizu T., Ohyama Y., Yokota Y., Ohtsuka K. Peripheral plasma concentrations of somatostatin-like immunoreactivity in newborns and infants. J. Clin. Endocrinol. Metab. 61: 78, 1985.
Nishihira M., Yagihashi S. Immunohistochemical demonstration of somatostatincontaining cells in human placenta. Tohoku J. Exp. Med. 126: 391, 1978.
Watkins W.B., Yen S.S.C. Somatostatin in cytotrophoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. J. Clin. Endocrinol. Metab. 50: 969, 1980.
Fitz-Patrick D., Patel Y.C. Evidence for somatostatin precursors in human stomach, placenta and amniotic fluid. J. Clin. Endocrinol. Metab. 53: 372, 1981.
Nan Lee J., Wu P., Chard T. Identification of somatostatin in the human placenta. Acta Endocrinol. (Kbh.) 99: 601, 1982.
Fitz-Patrick D., Patel Y.C. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid. J. Clin. Invest. 64: 737, 1979.
Dubois P.M., Paulin C., Assan R., Dubois M.P. Evidence for immunoreactive somatostatin in the endocrine cells of human foetal pancreas. Nature 256: 731, 1975.
Chayvialle J.A., Paulin C., Dubois P.M., Descos F., Dubois M.P. Ontogeny of somatostatin in the human gastro-intestinal tract, endocrine pancreas and hypothalamus. Acta Endocrinol. (Kbh.) 94: 1, 1980.
Goodyer C.G., St George Hall C., Guyda H., Robert F., Giroud J.P. Human fetal pituitary in culture: hormone secretion and response to somatostatin luteinizing hormone releasing factor, thyrotropin releasing factor and dibutyryl cyclic AMP. J. Clin. Endocrinol. Metab. 45: 73, 1977.
Oliver C., Giraud P., Lissitzky J.C., Cote J., Boudouresque F., Gillioz P., Conte-Delvox B. Influence of endogenous somatostatin on growth hormone and thyrotropin secretion in neonatal rats. Endocrinology 110: 1018, 1982.
Arimura A., Schally A.V. Increase in basal and thyrotropin-releasing hormone (TRH)-stimulated secretion of thyrotropin (TSH) by passive immunization with antiserum to somatostatin in rats. Endocrinology 98: 1069, 1976.
Theodoropoulos T.J. Somatostatin is a regulator of thyrotropin secretion in the perinatal rat. Endocrinology 117: 1683, 1985.
Sack J., Fisher D.A., Grajwer L.A., Lam R.W., Wang C.C. The response of newborn sheep to TRH with and without somatostatin. Endocrinology 100: 1533, 1977.
Roti E., Robuschi G., Alboni A., Emanuele R., d’Amato L., Gardini E., Salvi M., Dall’Aglio E., Gnudi A., Braverman L.E. Inhibition of foetal growth hormone (GH) and thyrotropin (TSH) secretion after maternal administration of somatostatin. Acta Endocrinol. (Kbh.) 106: 393, 1984.
Bertler A. Occurrence and localization of catecholamines in the human brain. Acta Physiol. Scand. 51: 97, 1961.
Gluckman P.D., Leisti S., Kaplan S.L., Grumbach M.M. Hormone ontogeny in the ovine fetus. XV. Studies of adenohypophyseal hormones after fetal pituitary stalk section: evidence for an extrahypothalamic dopaminergic influence on fetal prolactin secretion. Endocrinology 112: 1624, 1983.
Gluckman P.D., Marti-Henneberg C., Thomsett M.J., Kaplan S.L., Rudolph A.M., Grumbach M.M. Hormone ontogeny in the ovine fetus. VI. Dopaminergic regulation of prolactin secretion. Endocrinology 105: 1173, 1979.
Roti E., Robuschi G., Emanuele R., d’Amato L., Gnudi A., Fatone M., Benassi L., Foscolo M.S., Gualerzi C., Braverman L.E. Failure of metoclopramide to affect thyrotropin concentration in the term human fetus. J. Clin. Endocrinol. Metab. 56: 1071, 1983.
Roti E., Robuschi G., Alboni A., d’Amato L., Montermini M., Gardini E., Salvi M., Borciani E., Dall’Aglio E., Bisi S., Zammarchi G., Lasagni R., Gnudi A., Braverman L.E. Human foetal prolactin but not thyrotropin secretion is decreased by bromocriptine. Acta Endocrinol. (Kbh.) 112: 35, 1986.
Bigazzi M., Ronga R., Lancranjan I., Ferraro S., Branconi F., Buzzoni P., Martorana G., Scarselli G.F., Del Pozo E. A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J. Clin. Endocrinol. Metab 48: 9, 1979.
Miyakawa I., Taniyama K., Koike H., Mori N., Nagamine M., Kuribayashi T., Araki S. Successful pregnancy in an acromegalic patient during 2-Br-alpha-ergocryptine (CB-154) therapy. Acta Endocrinol. (Kbh.) 101: 333, 1982.
Author information
Authors and Affiliations
Additional information
This work was supported in part by Grants 84.01778.04 and 85.00533.04 of Consiglio Nazionale delle Ricerche, Rome, Italy.